Production of antibodies or (functionalized) fragments...

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069600, C435S069700, C435S070100, C435S254100, C424S130100, C424S134100

Reexamination Certificate

active

06838254

ABSTRACT:
A process is provided for the production of an antibody or a fragment or functionalized fragment thereof using a transformed lower eukaryotic host containing an expressible DNA sequence encoding the antibody or (functionalized) fragment thereof, wherein the antibody or (functionalized) fragment thereof is derived from a heavy chain immunoglobulin ofCamelidaeand is devoid of light chains, and wherein the lower eukaryotic host is a mould, preferably belonging to the generaAspergillusorTrichoderma,or a yeast, preferably belonging to the yeast generaSaccharomyces, Kluyveromyces, Hansenula, or Pichia. The heavy chain fragment can contain at least the whole variable domain. A complementary determining region (CDR) different from the CDR belonging to the natural antibody exCamelidaecan be grafted on the framework of the variable domain of the heavy chain immunoglobulin. The catalytic antibodies can be raised inCamelidaeagainst transition state molecules. The functionalized antibody or fragment thereof can comprise a fusion protein of both heavy chain immunoglobulin fromCamelidaeor a fragment thereof and another polypeptide, e.g., an enzyme, preferably an oxido-reductase. Also provided are new products obtainable by a process as described, and compositions containing a product produced by a process as described, which composition may contain a new product as provided.

REFERENCES:
patent: 5759808 (1998-06-01), Casterman et al.
patent: 5770445 (1998-06-01), Kindsvognel et al.
patent: 6005079 (1999-12-01), Casterman et al.
patent: 0 125 023 (1984-11-01), None
patent: 0 256 421 (1988-02-01), None
patent: 0 584 421 (1994-03-01), None
patent: WO 8909825 (1989-10-01), None
patent: WO 9108482 (1991-06-01), None
patent: WO 9302198 (1993-02-01), None
patent: WO 9404678 (1994-03-01), None
Ngo et al. Computational Complexity, Protein Structure Prediction and the Levinthal Paradox. The Protein Folding Problem and Tertiary Structure Prediction. K. Merz, Jr., and S. Le Grand, Editors, Birkhauser Boston, pp. 491-495, 1994.*
J. Rudinger in Peptide Hormones, J. A. Parsons (Ed.), University Park Press, Baltimore, MD, pp. 1-7, Jun. 1976.*
Hamers et al, Letters to Nature, vol. 363 (Jun. 3, 1993) pp. 446-449.
Davies et al, FEBS Letters, 339 (1994) pp. 285-290.
Ward et al, Nature, vol. 341 (1989) pp. 544-546.
Ungar-Waron et al, Isr. J. Vet. Med., vol. 43, No. 3, (1987), pp. 198-203.
Jones et al, Nature, vol. 321 (1986) pp. 522-525.
Dunnich et al, Nucleic Acids Research, vol. 8, No. 7 (1980) pp. 1475-1484.
Hochman et al, Biochemistry, vol. 12, No. 6 (1973) pp. 1130-1135.
Berry et al, Journal of Chromatography, vol. 597 (1992) pp. 239-245.
Hodgson, Biotechnology, vol. 9 (1991) pp. 421-424.
Breitling et al, Gene, vol. 184 (1991) pp. 147-153.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Production of antibodies or (functionalized) fragments... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of antibodies or (functionalized) fragments..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of antibodies or (functionalized) fragments... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3366990

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.